DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 884 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,355,801 | +22.7% | 13,526 | +18.7% | 0.29% | +20.7% |
| Q2 2023 | $2,735,520 | -20.3% | 11,398 | -16.3% | 0.24% | -25.0% |
| Q1 2023 | $3,431,273 | -0.3% | 13,614 | +5.0% | 0.32% | -7.9% |
| Q4 2022 | $3,441,170 | +2.3% | 12,965 | -0.4% | 0.34% | -5.8% |
| Q3 2022 | $3,363,000 | +12.7% | 13,022 | +10.7% | 0.36% | +15.6% |
| Q2 2022 | $2,983,000 | -25.2% | 11,765 | -13.5% | 0.32% | -9.2% |
| Q1 2022 | $3,988,000 | -8.4% | 13,597 | +2.7% | 0.35% | +23.9% |
| Q4 2021 | $4,356,000 | +10.9% | 13,239 | +2.6% | 0.28% | +3.3% |
| Q3 2021 | $3,928,000 | -27.6% | 12,905 | -36.2% | 0.27% | -25.5% |
| Q2 2021 | $5,429,000 | -10.4% | 20,231 | -24.8% | 0.36% | -15.3% |
| Q1 2021 | $6,056,000 | +4.0% | 26,904 | +2.7% | 0.43% | -3.2% |
| Q4 2020 | $5,821,000 | +2.7% | 26,202 | -0.4% | 0.44% | -7.9% |
| Q3 2020 | $5,668,000 | +16.5% | 26,320 | -4.4% | 0.48% | +3.0% |
| Q2 2020 | $4,866,000 | +31.5% | 27,522 | +2.9% | 0.47% | +6.8% |
| Q1 2020 | $3,700,000 | -18.3% | 26,735 | -9.3% | 0.44% | +4.5% |
| Q4 2019 | $4,526,000 | +1.1% | 29,492 | -4.9% | 0.42% | -5.0% |
| Q3 2019 | $4,478,000 | -1.1% | 31,002 | -2.1% | 0.44% | -2.6% |
| Q2 2019 | $4,526,000 | +6.7% | 31,669 | -1.5% | 0.45% | -1.7% |
| Q1 2019 | $4,243,000 | +29.8% | 32,139 | +1.4% | 0.46% | +27.3% |
| Q4 2018 | $3,270,000 | -7.5% | 31,703 | -2.6% | 0.36% | -1.4% |
| Q3 2018 | $3,537,000 | +5.6% | 32,556 | -4.1% | 0.37% | +3.1% |
| Q2 2018 | $3,351,000 | -3.9% | 33,956 | -4.7% | 0.36% | -3.8% |
| Q1 2018 | $3,487,000 | -6.7% | 35,613 | -11.6% | 0.37% | -0.8% |
| Q4 2017 | $3,738,000 | +2.4% | 40,271 | -5.3% | 0.37% | -9.7% |
| Q3 2017 | $3,649,000 | -13.0% | 42,542 | -14.4% | 0.41% | -18.1% |
| Q2 2017 | $4,194,000 | +3.1% | 49,703 | +4.5% | 0.50% | +2.2% |
| Q1 2017 | $4,068,000 | +10.9% | 47,562 | +0.9% | 0.49% | +8.8% |
| Q4 2016 | $3,668,000 | -7.2% | 47,122 | -6.6% | 0.45% | -7.9% |
| Q3 2016 | $3,953,000 | -10.4% | 50,437 | +15.4% | 0.49% | -13.1% |
| Q2 2016 | $4,414,000 | -1.6% | 43,699 | -7.6% | 0.57% | 0.0% |
| Q1 2016 | $4,484,000 | -2.5% | 47,268 | -4.5% | 0.57% | +10.8% |
| Q4 2015 | $4,597,000 | +14.3% | 49,491 | +4.8% | 0.51% | -4.3% |
| Q3 2015 | $4,023,000 | +9.4% | 47,217 | +9.8% | 0.53% | +25.6% |
| Q2 2015 | $3,679,000 | -1.1% | 42,990 | -1.9% | 0.42% | +3.4% |
| Q1 2015 | $3,720,000 | +44.5% | 43,817 | +45.8% | 0.41% | +48.4% |
| Q4 2014 | $2,575,000 | +17.3% | 30,043 | +4.0% | 0.28% | +12.6% |
| Q3 2014 | $2,195,000 | -2.2% | 28,889 | +1.4% | 0.25% | -1.2% |
| Q2 2014 | $2,244,000 | +7.9% | 28,494 | +2.7% | 0.25% | +7.3% |
| Q1 2014 | $2,080,000 | +7.4% | 27,732 | +10.6% | 0.23% | +8.4% |
| Q4 2013 | $1,936,000 | +6.0% | 25,077 | -4.8% | 0.21% | -4.5% |
| Q3 2013 | $1,826,000 | +5.1% | 26,337 | -4.0% | 0.22% | -3.4% |
| Q2 2013 | $1,737,000 | – | 27,432 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |